𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer

✍ Scribed by Sandro V. Porceddu; Elizabeth Jarmolowski; Rodney J. Hicks; Rob Ware; LeAnn Weih; Danny Rischin; June Corry; Lester J. Peters


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
217 KB
Volume
27
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Background. This study evaluates the utility of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) in patients with a node-positive mucosal head and neck squamous cell carcinoma who achieved a complete response at the primary site but had a residual mass in the neck 8 weeks or more after definitive (chemo)radiotherapy.

Methods. Between October 1996 and July 2002, 39 eligible patients were identified. The reference PET scan was performed at a median of 12 weeks (range, 8 -32 weeks) after treatment.

Results. PET showed no metabolic activity in the residual mass in 32 patients. Five of these patients had a neck dissection and were all pathologically negative. The remaining 27 patients were observed for a median of 34 months (range, 16 -86 months), with only one locoregional failure. The negative predictive value of PET for viable disease in a residual anatomic abnormality was 97%.

Conclusion. Patients who have achieved a complete response at the primary site but have a residual abnormality in the neck that is PET negative approximately 12 weeks after treatment do not require neck dissection and can be safely observed.


πŸ“œ SIMILAR VOLUMES


Positron emission tomography in the eval
✍ Theodoros N. Teknos; Eben L. Rosenthal; David Lee; Rodney Taylor; Charles S. Mar πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 205 KB πŸ‘ 2 views

## Abstract ## Background Detection of metastatic disease in head and neck cancer patients is critical to preoperative planning, because patients with distant metastasis will not benefit from surgical therapy. Conventional radiographic modalities, such as CT and MR, give excellent anatomic detail

Selective neck dissection in the managem
✍ Marc Hamoir; C.RenΓ© Leemans; Gilles Dolivet; Sandra Schmitz; Vincent GrΓ©goire; G πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 2 views

## Abstract For patients with advanced regional disease, neck dissection following (chemo)radiotherapy remains controversial. Selective neck dissection (SND) was reported as suitable after chemoradiation in patients with advanced regional disease. Reduced morbidity represents the major advantage of

Revisiting the role of positron-emission
✍ Christine G. Gourin; Brian J. Boyce; Hadyn T. Williams; Anne V. Herdman; Paul A. πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 148 KB πŸ‘ 1 views

## Abstract ## Objectives/Hypothesis: Planned neck dissection following chemoradiation (CR) has been advocated in patients with head and neck squamous cell cancer (HNSCC) with advanced nodal disease and a clinical complete response to CR because of the potential for residual occult nodal disease.

Accuracy of positron emission tomography
✍ Richard C. W. Martin; Michael Fulham; Kerwin F. Shannon; Ceri Hughes; Kan Gao; C πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 1 views

## Abstract ## Background The aim of this study was to evaluate the accuracy of positron emission tomography (PET) in assessing the patients treated with primary chemoradiotherapy for mucosal carcinoma of the head and neck. ## Methods A retrospective review of patients with biopsy‐proven cancer

18F-fluorodeoxyglucose dual-head positro
✍ Marcel P. M. Stokkel; Karel G. M. Moons; Frans-Willem ten Broek; Peter P. van Ri πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 157 KB πŸ‘ 2 views

## BACKGROUND. Second primary tumors are a leading cause of death among patients with head and neck cancer; therefore, early detection of these tumors is necessary. In the current study, the authors aimed to evaluate the diagnostic capacity of 18 F-fluorodeoxyglucose dual-head positron emission t